Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Actuarial Approach

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Quantifying treatment-related travel burden and its association with mortality in pediatric cancer: An analysis of state cancer registry data.

Cancer epidemiology·2026

Same author

Polarisome core component FgPea2 regulates FgBoi2-mediated polarized growth, pathogenicity and environmental stress in Fusarium graminearum.

Stress biology·2026

Same author

Genetic diversity analysis and core collection construction of Macadamia spp. from Yunnan using fourfold degenerate SNP sites.

BMC plant biology·2026

Same author

Case Report: Extracorporeal membrane oxygenation in acute coronary syndrome: a rare case of massive left ventricular thrombus.

Frontiers in cardiovascular medicine·2026

Same author

Exploring the Differences in Alkaloids of Fritillariae Thunbergii Bulbus From Different Regions Using Liquid Chromatography-Mass Spectrometry and Chemometrics.

Chemistry & biodiversity·2026

Same author

A comprehensive narrative review of <i>Epimedium</i> and its bioactive compounds in respiratory diseases.

Journal of pharmaceutical analysis·2026

Search research articles

Related Experiment Video

Updated: May 27, 2025

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Comparison of overall survival of adult and pediatric osteosarcoma patients using the national cancer database.

Ryan Boyland¹, Saber Amin², Valerie Shostrom³

¹Department of Emergency Medicine, Denver Health Medical Center, Denver, CO, USA.

|February 18, 2025

Summary

Pediatric osteosarcoma patients demonstrate better overall survival (OS) than adults. This survival advantage for children with osteosarcoma persists across various treatment types and cancer stages, warranting further investigation into underlying causes.

Keywords:

Hazard ratio Odds ratio Osteosarcoma Overall survival Pediatric

More Related Videos

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Published on: March 22, 2024

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Related Experiment Videos

Last Updated: May 27, 2025

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Published on: March 22, 2024

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Area of Science:

Oncology
Pediatric Oncology
Cancer Survival Analysis

Background:

Overall survival (OS) differences between pediatric and adult osteosarcoma patients remain unclear.
Understanding these disparities is crucial for improving treatment strategies.
The National Cancer Database (NCDB) provides a valuable resource for this comparative analysis.

Purpose of the Study:

To compare the overall survival (OS) of pediatric versus adult osteosarcoma patients.
To identify prognostic factors influencing OS in both age groups.
To explore specific factors associated with pediatric osteosarcoma outcomes.

Main Methods:

Analysis of osteosarcoma patient data from the National Cancer Database (NCDB) (2004-2017).
Inclusion criteria: Patients aged 1 year and older at diagnosis.
Multivariable Cox regression analysis to assess age-related OS differences and prognostic factors, adjusting for clinical and demographic variables.

Main Results:

Adult osteosarcoma patients exhibited significantly worse OS compared to pediatric patients (HR: 1.84, p < .01).
Pediatric patients showed improved OS across multiple treatment strata (chemotherapy alone, surgery alone, surgery plus chemotherapy, no treatment) and cancer stages.
No significant OS difference was observed between pediatric and adult patients receiving chemotherapy, surgery, and radiation therapy (RT) combined.

Conclusions:

Pediatric patients with osteosarcoma generally have better overall survival than adult patients.
This survival advantage in pediatric osteosarcoma is evident across different treatment modalities and cancer stages.
Further research is needed to determine the biological or clinical factors driving the improved OS in pediatric osteosarcoma.